Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01001845Phase 2Completed
A Phase 2 trial of silymarin in end stage renal disease (ESRD), sponsored by Shiraz University of Medical Sciences. Started Jun 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01001845.